Loperamide Hydrochloride Solution
NDC Package 81033-067-35
Package Information
Loperamide Hydrochloride solution is drink plenty of clear fluids to help prevent dehydration caused by diarrheafind right dose on chart. This formulation utilizes a solution delivery system. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-067 and is authorized under FDA application ANDA220100.
Identification & Billing
- RxCUI: 1250685 - loperamide HCl 1 MG in 7.5 mL Oral Suspension
- RxCUI: 1250685 - loperamide hydrochloride 0.133 MG/ML Oral Suspension
- RxCUI: 1250685 - loperamide HCl 1 MG per 7.5 ML Oral Solution
- RxCUI: 1250685 - loperamide hydrochloride 1 MG per 7.5 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81033 - Kesin Pharma Corporation
- 81033-067 - Loperamide Hydrochloride
- 81033-067-35 - 30 CUP, UNIT-DOSE in 1 CARTON / 15 mL in 1 CUP, UNIT-DOSE (81033-067-15)
- 81033-067 - Loperamide Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (81033-067). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81033-067-35 identifies a specific commercial package of 30 cup, unit-dose in 1 carton / 15 ml in 1 cup, unit-dose (81033-067-15) of Loperamide Hydrochloride, a human over the counter drug labeled by Kesin Pharma Corporation. This solution is formulated for oral use and contains loperamide hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kesin Pharma Corporation on November 13, 2024. The current certification is valid through December 31, 2027.
How is this Kesin Pharma Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033006735. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.